Study guide
12.1 Infective Endocarditis and NICE CG64
Overseas Registration Examination ORE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy
1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits
2 Chapter 2: Anatomy of the Head and Neck
2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection
3 Chapter 3: Dental Anatomy, Morphology and Occlusion
3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships
4 Chapter 4: Genetics, Embryology and Odontogenesis
4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies
5 Chapter 5: Oral Biology and Salivary Physiology
5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics
6 Chapter 6: Physiology of the Major Body Systems
6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System
7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing
7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk
8 Chapter 8: Oral Microbiology and Biofilm Ecology
8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control
9 Chapter 9: Immunology Relevant to Oral Disease
9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations
10 Chapter 10: General Pathology and Neoplasia
10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma
11 Chapter 11: Statistics and Research Methods
11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance
12 Chapter 12: Human Disease: Cardiovascular and Respiratory
12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies
13 Chapter 13: Human Disease: Endocrine, Haematological and Renal
13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis
14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological
14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis
15 Chapter 15: Oral Aspects of Human Disease
15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis
16 Chapter 16: Infection Prevention and Control
16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses
17 Chapter 17: Dental Materials
17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers
18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care
18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health
19 Chapter 19: Patient Assessment and Diagnosis
19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis
20 Chapter 20: Treatment Planning and Risk-Based Care
20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning
21 Chapter 21: Cariology and Caries Risk Assessment
21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment
22 Chapter 22: Operative Dentistry and Minimal Intervention
22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry
23 Chapter 23: Endodontics
23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture
24 Chapter 24: Periodontology
24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care
25 Chapter 25: Fixed Prosthodontics
25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements
26 Chapter 26: Removable Prosthodontics
26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration
27 Chapter 27: Paediatric Dentistry
27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits
28 Chapter 28: Dental Traumatology
28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications
29 Chapter 29: Orthodontics
29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention
30 Chapter 30: Oral Surgery
30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread
31 Chapter 31: Oral Medicine
31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
32 Chapter 32: Oral Pathology
32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms
33 Chapter 33: Therapeutics and Prescribing
33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics
34 Chapter 34: Medical Emergencies in Dental Practice
34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation
35 Chapter 35: Dental Radiology and Radiation Protection
35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017
36 Chapter 36: Special Care Dentistry and Conscious Sedation
36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral
37 Chapter 37: Dental Public Health
37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning
38 Chapter 38: Communication and Interpersonal Skills
38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team
39 Chapter 39: Consent and Capacity
39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure
40 Chapter 40: Clinical Professionalism and the GDC
40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle
41 Chapter 41: Health and Safety Law in Dental Practice
41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps
42 Chapter 42: Self-Management and Professional Development
42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management
12.1 Infective Endocarditis and NICE CG64
Key Takeaways Explain This Topic AI
NICE CG64 states that antibiotic prophylaxis against infective endocarditis is not recommended routinely for people undergoing dental procedures.
NICE lists acquired valvular heart disease with stenosis or regurgitation, valve replacement, structural congenital heart disease, previous infective endocarditis and hypertrophic cardiomyopathy as increased-risk conditions.
NICE explicitly does not recommend chlorhexidine mouthwash as prophylaxis before dental procedures.
The rationale is that cumulative daily bacteraemia from chewing and toothbrushing vastly exceeds that from a single dental appointment.
The UK preventive strategy is to maintain excellent oral health in at-risk patients rather than to give antibiotics.
Last updated: September 2026
1. Infective Endocarditis: The UK NICE CG64 Paradigm vs International Guidelines
Infective endocarditis (IE) is a severe, life-threatening infection of the cardiac endocardial surface, primarily targeting heart valves (native or prosthetic) or indwelling cardiac devices. It carries an in-hospital mortality rate approaching 20% to 30%. Historically, invasive dental procedures were assumed to be the primary precipitant of viridans group streptococcal endocarditis, leading to decades of routine pre-procedure antibiotic prophylaxis. In 2008, the UK National Institute for Health and Care Excellence (NICE) fundamentally transformed clinical practice by publishing Clinical Guideline 64 ( NICE CG64: Prophylaxis against infective endocarditis ).
The NICE CG64 Core Mandate
NICE CG64 states unequivocally that antibiotic prophylaxis against infective endocarditis is NOT routinely recommended for individuals undergoing dental procedures. This applies to all interventional dental procedures, regardless of the invasiveness of the treatment (including tooth extractions, periodontal subgingival scaling, endodontic surgery, and minor oral surgery) and regardless of the patient's underlying cardiac risk category. Patient Presents with High-Risk Cardiac Anomaly
- │
- ├── UK Practice (NICE CG64): Routine Antibiotic Prophylaxis is NOT Recommended
- │ ├── Do NOT administer oral or intravenous antibiotics prior to dental care
- │ ├── Do NOT offer pre-procedure chlorhexidine mouthwash
- │ ├── Reinforce meticulous personal oral hygiene and regular dental recalls
- │ └── Educate patient on early symptoms of IE (fever, chills, night sweats, fatigue)
- │
- └── US / European Practice (AHA / ESC Guidelines): Prophylaxis Recommended for High-Risk Only
- ├── Applies exclusively to high-risk cardiac conditions undergoing gingival/periapical manipulation
- └── Regimen: 2 g oral amoxicillin (or 600 mg clindamycin / 500 mg azithromycin if allergic) 30–60 mins pre-op
- Comparison: UK NICE vs AHA and ESC Guidelines
The UK guidance represents a sharp conceptual divergence from international guidelines, notably the American Heart Association (AHA) and European Society of Cardiology (ESC):
Feature UK NICE CG64 Guidance AHA & ESC Guidelines
Core Philosophy Non-routine prophylaxis across all risk groups Targeted prophylaxis restricted to highest-risk cardiac cohorts
High-Risk Categories Acknowledged as high risk, but routine prophylaxis still withheld Specifically indicated for antibiotic coverage prior to invasive dental care
Prophylactic Antibiotics Not recommended Recommended (e.g., Amoxicillin 2 g orally 30–60 min pre-procedure)
Pre-op Chlorhexidine Mouthwash Explicitly NOT recommended Not routinely recommended, but not explicitly prohibited
Procedures Covered None routinely Only procedures manipulating gingival tissue, periapical region, or perforating oral mucosa
High-Risk Cardiac Conditions Categorised by NICE
NICE CG64 categorises patients with the following pre-existing structural cardiac anomalies as being at increased risk of developing infective endocarditis (even though routine dental prophylaxis is withheld):
Acquired valvular heart disease with stenosis or regurgitation (e.g., calcific aortic stenosis, mitral regurgitation, rheumatic heart disease).
Hypertrophic cardiomyopathy .
Previous episode of infective endocarditis (highest risk of recurrence and mortality).
Prosthetic valve replacement (including mechanical valves, bioprosthetic tissue valves, and transcatheter aortic valve implantations [TAVI]).
Structural congenital heart disease , including:
Surgically corrected or palliated conditions (e.g., repaired Tetralogy of Fallot, Fontan circulation).
Complex cyanotic heart disease.
Exclusions: Isolated atrial septal defects (ASD), fully repaired ventricular septal defects (VSD), and fully repaired patent ductus arteriosus (PDA) after 6 months are not considered at increased risk.
Scientific Rationale for Withholding Routine Prophylaxis
The NICE guideline development group based its paradigm-shifting policy on robust epidemiological, microbiological, and pharmacological evidence:
Cumulative Daily Transient Bacteremia: Transient low-grade viridans streptococcal bacteremia occurs repeatedly during everyday physiological activities: mastication (chewing food: 7–51%), toothbrushing (20–68%), and dental flossing (20–40%). Over a year, an individual is exposed to physiological bacteremia thousands of times more frequently than during an isolated dental extraction. Cumulative daily exposure dwarfs procedural exposure.
Lack of Definitive Evidence: No prospective, randomized, controlled clinical trial has ever demonstrated that pre-procedure antibiotic prophylaxis reduces the incidence, morbidity, or mortality of infective endocarditis in humans.
Antimicrobial Stewardship & Adverse Drug Reactions: Routine administration of broad-spectrum amoxicillin carries a quantifiable risk of fatal IgE-mediated anaphylaxis (approximately 1 in 100,000 administrations), Clostridioides difficile pseudomembranous colitis, and the acceleration of community-wide antimicrobial resistance. The theoretical benefit of preventing an extraordinarily rare case of IE is heavily outweighed by the verified mortality and morbidity of widespread antibiotic prescribing.
The Role of Chlorhexidine Mouthwash
NICE CG64 explicitly advises that chlorhexidine mouthwash should NOT be offered as prophylaxis against infective endocarditis to patients undergoing dental procedures. While 0.2% chlorhexidine gluconate transiently reduces surface salivary bacterial counts, clinical trials have proven that it does not significantly abolish or diminish the magnitude or duration of subgingival bacteremia entering the systemic circulation following tooth extraction or scaling.
Core Preventive Dental Strategy under NICE
Rather than relying on chemical prophylaxis, NICE mandates that general dental practitioners must:
Emphasize the vital importance of maintaining meticulous personal oral hygiene to minimize chronic gingival inflammation and transient bacteremia.
Advise high-risk cardiac patients to attend regular dental examinations and maintain periodontal stability.
Treat active oral and dental infections promptly to eliminate chronic reservoirs of infection.
Provide clear verbal and written education on the warning symptoms of infective endocarditis (unexplained persistent fever, nocturnal diaphoresis, unexplained weight loss, malaise, dyspnoea, peripheral petechiae, splinter haemorrhages) and instruct them to seek urgent medical attention should these symptoms develop.
Important
The 2015/2016 NICE Clarification on Clinical Discretion: Following continuous professional debate and judicial review, NICE published an official clarification in 2016. While reaffirming that antibiotic prophylaxis is not routinely recommended, NICE clarified that the word "routinely" permits clinical discretion: in rare, exceptional circumstances, if a high-risk patient's cardiologist strongly recommends prophylaxis after an individualised risk assessment, or if a fully informed patient requests it, the treating clinician may prescribe prophylaxis within a shared decision-making framework. However, in the UK ORE Part 1 examination, the standard, legally defensible first-line answer remains that routine prophylaxis is NOT recommended .